Introducing Silence Therapeutics - Mark Rothera, President and CEO of Silence Therapeutics 00:00:00

Share On Facebook Share On Twitter

Silence Therapeutics is developing a new generation of medicines by harnessing the body’s natural mechanism of RNAi (RNA interference) to precisely target and silence disease-associated genes.

Recent Videos